Stem Cell Transplant News

Stem Cell Transplant Procedures Vary Throughout the World (05/09/2008)
Stem cell transplant practices vary substantially among physicians treating adults and children with hematologic malignancies (cancers of the blood or bone marrow such as leukemias and lymphomas).  These findings were published in the Journal of Clinical Oncology.

Use of Antifungal Agents Decreases Death in Allogeneic Stem Cell Transplants (12/04/2007)
According to an article recently published in the Journal of Clinical Oncology, preventive use of antifungal agents improves survival among patients undergoing an allogeneic stem cell transplant.

Allogeneic Stem Cell Transplants Associated with Risk for Diabetes and Hypertension (02/07/2007)
According to an article recently published in the journal Blood, allogeneic stem cell transplants are associated with an increased risk of diabetes and hypertension.

Umbilical Cord Transplants Provide Same Outcomes as Related Allogeneic Stem Cell Transplants (02/07/2007)
According to an article recently published in Blood, using umbilical cord blood for stem cell transplants provides results that are similar to or better than results of an allogeneic stem cell transplant utilizing stem cells from a related donor.

MCP Chemotherapy Regimen May Reduce Amount of Stem Cells Collected in Follicular Lymphoma (02/01/2007)
According to results recently published in Annals of Oncology, the chemotherapy regimen consisting of melphalan, chlorambucil, and prednisone (MCP) appears to interfere with the ability to collect enough stem cells for an autologous stem cell transplant in patients with follicular non-Hodgkin’s lymphoma (NHL).

More...

Allogeneic Stem Cell Transplant

Stem Cell Transplant Procedures Vary Throughout the World (05/09/2008)
Stem cell transplant practices vary substantially among physicians treating adults and children with hematologic malignancies (cancers of the blood or bone marrow such as leukemias and lymphomas).  These findings were published in the Journal of Clinical Oncology.

Use of Antifungal Agents Decreases Death in Allogeneic Stem Cell Transplants (12/04/2007)
According to an article recently published in the Journal of Clinical Oncology, preventive use of antifungal agents improves survival among patients undergoing an allogeneic stem cell transplant.

Allogeneic Stem Cell Transplants Associated with Risk for Diabetes and Hypertension (02/07/2007)
According to an article recently published in the journal Blood, allogeneic stem cell transplants are associated with an increased risk of diabetes and hypertension.

Umbilical Cord Transplants Provide Same Outcomes as Related Allogeneic Stem Cell Transplants (02/07/2007)
According to an article recently published in Blood, using umbilical cord blood for stem cell transplants provides results that are similar to or better than results of an allogeneic stem cell transplant utilizing stem cells from a related donor.

Noxavil® May be Superior for Prevention of Fungal Infections in Cancer Patients (01/26/2007)
According to two articles recently published in the New England Journal of Medicine, the anti-fungal agent Novaxil® (posaconazole) may be superior to other anti-fungals in cancer patients who are at a high risk for developing a fungal infection.

More...

Autologous Stem Cell Transplant

Stem Cell Transplant Procedures Vary Throughout the World (05/09/2008)
Stem cell transplant practices vary substantially among physicians treating adults and children with hematologic malignancies (cancers of the blood or bone marrow such as leukemias and lymphomas).  These findings were published in the Journal of Clinical Oncology.

MCP Chemotherapy Regimen May Reduce Amount of Stem Cells Collected in Follicular Lymphoma (02/01/2007)
According to results recently published in Annals of Oncology, the chemotherapy regimen consisting of melphalan, chlorambucil, and prednisone (MCP) appears to interfere with the ability to collect enough stem cells for an autologous stem cell transplant in patients with follicular non-Hodgkin’s lymphoma (NHL).

At-home Stem Cell Transplantation Reduces Cost and Hospital Time (10/26/2006)
According to an article recently published in the Journal of Clinical Oncology, at-home treatment for an autologous stem cell transplant reduces medical cost and hospital stay among patients with hematologic (blood) malignancies.

Presence of Cancer Cells in Circulating Blood Predicts Worse Outcomes After High-dose Therapy in Breast Cancer (08/01/2006)
According to an article recently published in the Journal of Clinical Oncology, the presence of small amounts of cancer cells in circulating blood as detected by a gene panel predicts a 300% increased risk of death among women with early breast cancer who undergo high-dose therapy and a stem cell transplant.

Certain Variables Predict Risk of Secondary Leukemia After Stem Cell Transplant (07/31/2006)
According to an article recently published in the Journal of Clinical Oncology, patients diagnosed with lymphoma who were previously treated with radiation therapy, those treated with four or more chemotherapy regimens, and those who take five days to collect enough stem cells for a transplant are at a higher risk of developing myelodysplastic syndromes or acute myeloid leukemia associated with a stem cell transplant.

More...